COMMUNIQUÉS West-GlobeNewswire

Rocket delivers cell samples to ISS to study effects of microgravity on muscles
19/11/2018
Muscle cells from Florida Hospital’s Translational Research Institute will be used to develop treatments for age-related muscle loss. ORLANDO, Fla., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Several Central Floridians are on a [...]
TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar® in Patients with Recurrent Glioblastoma at Society for Neuro-Oncology Annual Meeting
19/11/2018
SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Teladoc Health to Participate in Upcoming Investor Conference
19/11/2018
PURCHASE, NY, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]
Anchiano Therapeutics Reports Third Quarter 2018 Financial and Operational Results
19/11/2018
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration
19/11/2018
ADVM-022 is the first intravitreally delivered gene therapy utilizing directed evolution AAV.7m8 vector for wet AMD OPTIC trial to evaluate single administration of ADVM-022 for wet AMD Interim trial update expected by [...]
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement in Progressive Multiple Sclerosis Patients Treated with ATA190, an Autologous Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy
19/11/2018
Findings reported in an article online and to be published in the December 2018 issue of the JCI Insight SOUTH SAN FRANCISCO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a [...]
AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day
19/11/2018
Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion Announces Market Development and Clinical Initiatives for Expanded Application in the Surgical Treatment of Chronic [...]
American Diabetes Association Colorado appoints Chief Medical Officer of Allscripts Analytics as New Member to Community Leadership Board
19/11/2018
DENVER and CHICAGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- The American Diabetes Association along with Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) announced today that the American Diabetes Association Colorado has [...]
OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)
19/11/2018
Sponsorship includes a pre-course meeting in addition to four workshops on a variety of topics WARSAW, Ind., Nov. 19, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on [...]
Foamix Announces Appointment of Anthony Bruno to Board of Directors
19/11/2018
REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing [...]
Dermira to Present at Evercore ISI HealthCONx Conference
19/11/2018
MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Invivoscribe soumet le test de mutation LeukoStrat CDx FLT3 pour soutenir la soumission de Daiichi Sankyo pour le Quizartinib au Japon
19/11/2018
SAN DIEGO, 19 nov. 2018 (GLOBE NEWSWIRE) -- En soutien à un partenariat en cours avec Daiichi Sankyo, Invivoscribe a le plaisir d'annoncer la soumission du LeukoStrat ® CDx FLT3 Mutation Assay (test de mutation [...]
Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan
19/11/2018
SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- In support of an ongoing partnership with Daiichi Sankyo, Invivoscribe is pleased to announce submission of the LeukoStrat ® CDx FLT3 Mutation Assay to the PMDA ( [...]
Minerva Neurosciences Announces Results of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered at Supra-Therapeutic Doses in Healthy Volunteers
19/11/2018
Findings suggest expanded therapeutic window and significantly improved cardiovascular safety margin compared to formulation used in Phase 2b trial All doses tested up to 256 milligrams appear safe and well tolerated [...]
Ceapro Inc. Announces Completion of Successful Audits by Major Customers
19/11/2018
- New Edmonton-based facility fully commissioned and first orders shipped - Filed for a Drug Establishment License from Health Canada to allow the Company to handle biopharmaceuticals products EDMONTON, Alberta, Nov. 19 [...]
BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis
19/11/2018
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, today [...]
Concierge Care Samaritans Makes Monetary Donation to the Federal Way Senior Center
19/11/2018
SEATTLE, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Concierge Care Advisors , Washington’s premier senior living and care resource agency, today announced its Concierge Care Samaritans have provided a monetary donation of $1,000 [...]
Samumed Doses First Subject in Phase 2/3 Trial of SM04554 for the Treatment of Androgenetic Alopecia
19/11/2018
Top-line Data Expected in Second Half of 2020 SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it has dosed the first subject in its phase 2/3 trial of SM04554, a topical small molecule [...]
Aura Announces Appointment of New Chief Operating Officer and Board Approval of Stock-Based Compensation Plan
19/11/2018
TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Aura Health Inc. (the " Company " or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the appointment of Howard Brass to the role of Chief Operating Officer, effective immediately [...]

Pages